Gene Logic finds Parkinson's markers:
This article was originally published in Clinica
A collaboration involving US firm Gene Logic has identified biomarkers that predict susceptibility to Parkinson's disease and age of disease onset, the Gaithersburg, Maryland company has reported. In a study, conducted with the Mayo Clinic in the US, the company provided gene expression data analysis and data interpretation, comparing the whole-genome study data with the company's Parkinson's disease gene expression knowledge-base. The firm believes that the study augments its intellectual property position around a growing set of useful markers for Parkinson's disease and other complex diseases, affording "excellent" opportunities to develop diagnostic, prognostic or therapeutic products.